(Q36688370)

15 August 2017

1 reference

title

T cell-directed therapies: lessons learned and future prospects (English)

1 reference

15 August 2017

1 reference

Eric H Liu

1

1 reference

15 August 2017

Richard M Siegel

series ordinal

2

1 reference

15 August 2017

David M Harlan

series ordinal

3

1 reference

15 August 2017

John J O'Shea

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

25-30

1 reference

Jurkat T cells and development of the T-cell receptor signalling paradigm

15 August 2017

cites work

1 reference

The clinical use of antilymphocyte globulin in renal homotransplantation

21 January 2018

1 reference

An open trial of OKT3 in patients with multiple sclerosis

21 January 2018

1 reference

In vitro characterization of five humanized OKT3 effector function variant antibodies.

21 January 2018

1 reference

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.

21 January 2018

1 reference

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study

21 January 2018

1 reference

Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody

21 January 2018

1 reference

Antigen-induced programmed T cell death as a new approach to immune therapy

21 January 2018

1 reference

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

21 January 2018

1 reference

How do CD4+CD25+ regulatory T cells control autoimmunity?

21 January 2018

1 reference

Calcium, calcineurin, and the control of transcription

21 January 2018

1 reference

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses

21 January 2018

1 reference

CTLA4Ig: bridging the basic immunology with clinical application

21 January 2018

1 reference

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

21 January 2018

1 reference

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells

21 January 2018

1 reference

Immunology. Considering therapeutic antibodies

21 January 2018

1 reference

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

21 January 2018

1 reference

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

21 January 2018

1 reference

IL-15 in the life and death of lymphocytes: immunotherapeutic implications

21 January 2018

1 reference

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease

21 January 2018

1 reference

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

21 January 2018

1 reference

Anti-interleukin-12 antibody for active Crohn's disease

21 January 2018

1 reference

Genetic dissection of immunity to mycobacteria: the human model

21 January 2018

1 reference

Signaling by type I and II cytokine receptors: ten years after

21 January 2018

1 reference

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

21 January 2018

1 reference

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

21 January 2018

1 reference

A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity

21 January 2018

1 reference

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity

21 January 2018

1 reference

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

21 January 2018

1 reference

Inhibitors of cytokine signal transduction

21 January 2018

1 reference

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

21 January 2018

1 reference

GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

21 January 2018

1 reference

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

FTY720: altered lymphocyte traffic results in allograft protection

21 January 2018

1 reference

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation

21 January 2018

1 reference

Oral fingolimod (FTY720) for relapsing multiple sclerosis

21 January 2018

1 reference

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

21 January 2018

1 reference

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

21 January 2018

1 reference

7 January 2021

Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome

1 reference

7 January 2021

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

1 reference

7 January 2021

Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trial

1 reference

7 January 2021

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

7 January 2021

Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics

1 reference

7 January 2021

Cyclosporine as a milestone in immunosuppression

1 reference

7 January 2021

Calcineurin: form and function

1 reference

7 January 2021

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

7 January 2021

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1 reference

7 January 2021

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

1 reference

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI1429

1 reference

15 August 2017

1 reference